Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1 2 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Prostatic Neoplasms 8 Brain Neoplasms 7 Head and Neck Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Intraductal, Noninfiltrating 4 Uterine Cervical Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Glioblastoma 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma, Ductal, Breast 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Tonsillar Neoplasms 1 Symptomatic Osseous Bone Lesions From Any Malignancy 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1

Interventions

Radiotherapy 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Cyclosporine 7 Cyclophosphamide 7 Busulfan 7 Whole-Body Irradiation 6 Melphalan 6 Radiofrequency Ablation 5 Mycophenolic Acid 5 Filgrastim 5 Antilymphocyte Serum 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Methotrexate 4 Etoposide 4 Drug Therapy 4 Cisplatin 4 fludarabine 3 Radiosurgery 3 Injections 3 Hepatectomy 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 lenvatinib 2 Vinblastine 2 Videotape Recording 2 Thiotepa 2 Standard of Care 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Radiation × Clear all

NCT00975520 2024-11-27

RTN2

Melanoma and Skin Cancer Trials Limited

Phase NA Completed

Melanoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡